Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe (SUPPORT-TB) Activity | 72061324RFA00001

Opportunity Information: Apply for 72061324RFA00001

The Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe (SUPPORT-TB) Activity is a USAID Zimbabwe (USAID-Harare) funding opportunity focused on strengthening Zimbabwe's national response to tuberculosis and improving health outcomes for people and communities affected by TB. The activity is designed to benefit not only individuals with TB, but also health workers, families, and communities by improving how TB is found, treated, prevented, and managed across the health system. The opportunity is structured as a cooperative agreement, which typically means USAID expects to play an active role during implementation through ongoing collaboration, technical engagement, and performance oversight, rather than simply issuing a grant and stepping back.

At the center of the opportunity are four linked program objectives that together cover the full TB care and prevention continuum. Objective 1 is to improve TB case detection, meaning the activity will prioritize finding more people with TB earlier and more reliably, including those who may be missed by routine services. This can include improving screening approaches, strengthening diagnostic networks and referral pathways, increasing demand for testing, and reducing barriers that prevent people from being identified and diagnosed in time. Better case detection is critical because undiagnosed or late-diagnosed TB drives ongoing transmission and worsens individual outcomes.

Objective 2 is to strengthen TB case management for all forms of TB, which signals a comprehensive approach to treatment and clinical follow-up across different TB presentations. This includes ensuring patients are correctly initiated on appropriate regimens, supported to complete treatment, monitored for response and side effects, and managed effectively when complications arise. "All forms of TB" generally points to the need to address drug-susceptible TB as well as more complex forms such as drug-resistant TB, and to ensure services work for different populations and clinical contexts. Stronger case management also implies improvements in service quality, continuity of care, patient support, and coordination between facilities and community-based systems so that people do not fall out of care.

Objective 3 focuses on preventing new TB infections and stopping TB infection from progressing to active disease. This prevention pillar typically involves infection prevention and control measures in health facilities and congregate settings, systematic contact investigation, and provision of preventive therapy for eligible individuals at higher risk of developing active TB. Prevention also often includes community-level approaches that reduce exposure and improve early action, along with integration with other health services where TB risk is elevated. The aim here is to reduce transmission and lower the future burden of disease, not just treat cases that are already active.

Objective 4 is to strengthen local systems for planning, coordinating, monitoring, and assuring the quality of TB services. This objective highlights that the activity is not only about delivering services, but also about reinforcing the underlying structures that make TB programming effective and sustainable. It points to strengthening coordination mechanisms, data systems, performance monitoring, supportive supervision, and quality improvement processes. The emphasis on local systems suggests a focus on building durable capacity within Zimbabwean institutions to manage TB programs effectively over time, including ensuring that planning and oversight functions are robust, evidence-driven, and accountable for results.

In terms of funding and administrative details, the opportunity is listed as a discretionary award under CFDA 98.001 and is offered by USAID-Harare. The funding opportunity number is 72061324RFA00001, and USAID anticipates making one award, with an award ceiling of USD 29,000,000. The original closing date for applications was 2024-07-31, and the opportunity record indicates a creation date of 2024-06-28. Eligibility is listed broadly as "Others," and the notice references a specific definition of "local entities" contained in the attached Notice of Funding Opportunity (NOFO), meaning applicants will need to consult that document to confirm whether they qualify under USAID's local entity requirements and any additional conditions tied to local leadership or local capacity strengthening.

Overall, SUPPORT-TB is framed as a single, large cooperative agreement intended to scale and improve the TB response in Zimbabwe across detection, treatment, prevention, and health system strengthening. The structure and objectives indicate USAID is seeking an implementer (or consortium) capable of working across community and facility settings, supporting national and subnational TB program functions, improving service quality and performance, and producing measurable improvements in TB outcomes while reinforcing sustainable, locally anchored systems.

• The Zimbabwe USAID-Harare in the health sector is offering a public funding opportunity titled "Scaling Up Prevention, Oversight, Reach and Treatment of Tuberculosis in Zimbabwe (SUPPORT-TB) Activity" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
• This funding opportunity was created on 2024-06-28.
• Applicants must submit their applications by 2024-07-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $29,000,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others.

Apply for 72061324RFA00001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: